Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models

E Mohr, T Thum, C Bär - European journal of heart failure, 2022 - Wiley Online Library
In vitro modelling the complex (patho‐) physiological conditions of the heart is a major
challenge in cardiovascular research. In recent years, methods based on three‐dimensional …

Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk …

SD Burnett, AD Blanchette, WA Chiu… - Expert opinion on drug …, 2021 - Taylor & Francis
Introduction Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes is one of
the most widely used cell-based models that resulted from the discovery of how non …

Assessing drug-induced mitochondrial toxicity in cardiomyocytes: implications for preclinical cardiac safety evaluation

X Tang, Z Wang, S Hu, B Zhou - Pharmaceutics, 2022 - mdpi.com
Drug-induced cardiotoxicity not only leads to the attrition of drugs during development, but
also contributes to the high morbidity and mortality rates of cardiovascular diseases …

Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease

W Lin, F Mousavi, BC Blum, CF Heckendorf… - Frontiers in …, 2023 - frontiersin.org
Background: We hypothesize that the poor survival outcomes of end-stage kidney disease
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …

Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)

WP Bozza, K Takeda, WL Alterovitz, CK Chou… - The AAPS journal, 2021 - Springer
Anthracyclines are a class of chemotherapy drugs that are highly effective for the treatment
of human cancers, but their clinical use is limited by associated dose-dependent …

An efficient human stem cells derived cardiotoxicity testing platform for testing oncotherapeutic analogues of quercetin and cinnamic acid

S Mandal, N Gamit, S Biswas, CM Rao, G Sethi… - Scientific Reports, 2022 - nature.com
Oncotherapeutics research is progressing at a rapid pace, however, not many drugs
complete the successful clinical trial because of severe off-target toxicity to cardiomyocytes …

Importance of evaluating protein glycosylation in pluripotent stem cell-derived cardiomyocytes for research and clinical applications

MI Kelly, M Albahrani, C Castro, E Poon, B Yan… - … -European Journal of …, 2021 - Springer
Proper protein glycosylation is critical to normal cardiomyocyte physiology. Aberrant
glycosylation can alter protein localization, structure, drug interactions, and cellular function …

The new era of cardiovascular research: revolutionizing cardiovascular research with 3D models in a dish

Y Yang, H Yang, FN Kiskin, JZ Zhang - Medical Review, 2024 - degruyter.com
Cardiovascular research has heavily relied on studies using patient samples and animal
models. However, patient studies often miss the data from the crucial early stage of …